A biological response modifier, PSK, inhibits human immunodeficiency virus infection in vitro
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 148 (2), 726-733
- https://doi.org/10.1016/0006-291x(87)90936-3
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicityNature, 1986
- AIDS Retrovirus Induced Cytopathology: Giant Cell Formation and Involvement of CD4 antigenScience, 1986
- Establishment of a high production system for AIDS retroviruses with a human T-leukemic cell line Molt-4Cancer Letters, 1986
- Binding of HTLV-III/LAV to T4 + T Cells by a Complex of the 110K Viral Protein and the T4 MoleculeScience, 1986
- Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque AssayScience, 1985
- T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAVNature, 1984
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984
- Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T LymphocytesScience, 1984
- Krestin (PSK)Cancer Treatment Reviews, 1984
- Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDSScience, 1984